OpenAI's CEO Sam Altman says in 10 years time college graduates will be working 'some completely new, exciting, super well-paid' job in space - Fortune

Wegovy® approved by FDA for the treatment of adults with noncirrhotic MASH with moderate to advanced liver fibrosis – PR Newswire

August 17, 2025

Wegovy® approved by FDA for the treatment of adults with noncirrhotic MASH with moderate to advanced liver fibrosis PR NewswireNovo Nordisk’s Wegovy gets accelerated US approval for liver disease MASH ReutersNovo Nordisk announces FDA approves additional indication of Wegovy TipRanksNovo Nordisk’s Wegovy Gets US Approval for Liver Disease Bloomberg.comNovo Nordisk’s Wegovy Expands into the MASH Market: A Strategic Catalyst for Long-Term Growth AInvest